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NO/cGMP signalling via cGMP-dependent kinase I
(cGKI) induces a variety of physiological functions com-
prising relaxation of smooth muscle and inhibition of
platelet aggregation. Several signalling pathways of cGKI
exist including the interaction of the cGKIβ isozyme with
the inositol 1,4,5-trisphosphate receptor I (IP3RI) associ-
ated protein cGMP kinase substrate (IRAG). To get insight
into the physiological function of IRAG protein a knock-
out mutant of the IRAG gene was generated by targeted
deletion. Expression of other cGKI substrate proteins in
mutant smooth muscle tissues and platelets was not
affected upon IRAG deletion. Interestingly, the localiza-
tion of cGKIβ was unchanged in IRAG-deficient vascular
smooth muscle cells. Analysis of smooth muscle contrac-
tility suggests that signalling via IRAG is essential for
endogenous and exogenous NO/cGMP-dependent con-
tractility of aortic smooth muscle. Furthermore, NO/
cGMP-dependent relaxation of murine colon is depend-
ent on this signalling cascade. In platelets, IRAG-defi-
ciency abolishes the NO/cGMP-dependent inhibition of
platelet aggregation and granule secretion. These results
strongly suggest that IRAG signalling is a predominant
physiological signalling pathway of NO/cGMP in smooth
muscle and platelets.
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